Secondary Prevention of Venous Thrombo Embolism (VTE).

NCT00329238 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2867

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism

Interventions

DRUG: Dabigatran
DRUG: Warfarin

Sponsor

Boehringer Ingelheim